BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 697751)

  • 1. The activity of glucagon-stimulated adenylate cyclase from rat liver plasma membranes is modulated by the fluidity of its lipid environment.
    Dipple I; Houslay MD
    Biochem J; 1978 Jul; 174(1):179-90. PubMed ID: 697751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the form of Arrhenius plots of the activity of glucagon-stimulated adenylate cyclase and other hamster liver plasma-membrane enzymes occurring on hibernation.
    Houslay MD; Palmer RW
    Biochem J; 1978 Sep; 174(3):909-19. PubMed ID: 728095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic phospholipid species inhibit adenylate cyclase activity in rat liver plasma membranes.
    Houslay MD; Needham L; Dodd NJ; Grey AM
    Biochem J; 1986 Apr; 235(1):237-43. PubMed ID: 3741383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of dopamine-stimulated adenylate cyclase from rat brain stratum is modulated by temperature and the bilayer-fluidizing agent, benzyl alcohol.
    Needham L; Houslay MD
    Biochem J; 1982 Jul; 206(1):89-95. PubMed ID: 7126197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated membrane cholesterol concentrations inhibit glucagon-stimulated adenylate cyclase.
    Whetton AD; Gordon LM; Houslay MD
    Biochem J; 1983 Feb; 210(2):437-49. PubMed ID: 6305341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
    Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbital selectively modulates the glucagon-stimulated activity of adenylate cyclase by depressing the lipid phase separation occurring in the outer half of the bilayer of liver plasma membranes.
    Houslay MD; Dipple I; Gordon LM
    Biochem J; 1981 Sep; 197(3):675-81. PubMed ID: 7325977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-stimulated adenylate cyclase detects a selective perturbation of the inner half of the liver plasma-membrane bilayer achieved by the local anaesthetic prilocaine.
    Houslay MD; Dipple I; Rawal S; Sauerheber RD; Esgate JA; Gordon LM
    Biochem J; 1980 Jul; 190(1):131-7. PubMed ID: 6255940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of temperature and benzyl alcohol on the structure and adenylate cyclase activity of plasma membranes from bovine adrenal cortex.
    de Foresta B; Rogard M; le Maire M; Gallay J
    Biochim Biophys Acta; 1987 Dec; 905(2):240-56. PubMed ID: 2825779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase.
    Houslay MD; Dipple I; Elliott KR
    Biochem J; 1980 Mar; 186(3):649-58. PubMed ID: 6249258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity.
    Whetton AD; Needham L; Dodd NJ; Heyworth CM; Houslay MD
    Biochem Pharmacol; 1983 May; 32(10):1601-8. PubMed ID: 6305364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimethylnitrosamine inhibits the glucagon-stimulated adenylate cyclase activity of rat liver plasma membranes and decreases plasma membrane fluidity.
    Whetton AD; Needham L; Margison GP; Dodd NJ; Houslay MD
    Biochim Biophys Acta; 1984 Jun; 773(1):106-12. PubMed ID: 6329276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbations of liver plasma membranes induced by Ca2+ are detected using a fatty acid spin label and adenylate cyclase as membrane probes.
    Gordon LM; Whetton AD; Rawal S; Esgate JA; Houslay MD
    Biochim Biophys Acta; 1983 Mar; 729(1):104-14. PubMed ID: 6299344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
    Howlett AC; Scott DK; Wilken GH
    Biochem Pharmacol; 1989 Oct; 38(19):3297-304. PubMed ID: 2554920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine and melittin both decrease the fluidity of liver plasma membranes and both inhibit hormone-stimulated adenylate cyclase activity.
    Needham L; Dodd NJ; Houslay MD
    Biochim Biophys Acta; 1987 May; 899(1):44-50. PubMed ID: 3032256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenylate cyclase is inhibited upon depletion of plasma-membrane cholesterol.
    Whetton AD; Gordon LM; Houslay MD
    Biochem J; 1983 May; 212(2):331-8. PubMed ID: 6309140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective effects of charged local anaesthetics on the glucagon- and fluoride-stimulated adenylate cyclase activity of rat-liver plasma membranes.
    Gordon LM; Dipple I; Sauerheber RD; Esgate JA; Houslay MD
    J Supramol Struct; 1980; 14(1):21-32. PubMed ID: 7218799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4-hydroxynonenal on adenylate cyclase and 5'-nucleotidase activities in rat liver plasma membranes.
    Paradisi L; Panagini C; Parola M; Barrera G; Dianzani MU
    Chem Biol Interact; 1985; 53(1-2):209-17. PubMed ID: 2986858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of glucagon activation of adenylate cyclase in the presence of Mn2+.
    Houslay MD; Heyworth CM; Whetton AD
    FEBS Lett; 1983 May; 155(2):311-6. PubMed ID: 6303847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceratitis capitata brain adenylate cyclase and its membrane environment.
    Guillen A; Haro A; Gavilanes FG; Municio AM
    Arch Biochem Biophys; 1991 May; 286(2):591-5. PubMed ID: 1897980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.